Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Improvement of gene expression analysis by RQ-PCR technology: addition of BSA

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. de Haas V, Breunis WB, Dee R, Verhagen OJ, Kroes W, van Wering ER et al. The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia. Br J Haematol 2002; 116: 87–93.

    Article  CAS  Google Scholar 

  2. Moppett J, van der Velden VH, Wijkhuijs AJ, Hancock J, van Dongen JJ, Goulden N . Inhibition affecting RQ-PCR-based assessment of minimal residual disease in acute lymphoblastic leukemia: reversal by addition of bovine serum albumin. Leukemia 2003; 17: 268–270.

    Article  CAS  Google Scholar 

  3. Abu Al-Soud W, Radstrom P . Effects of amplification facilitators on diagnostic PCR in the presence of blood, feces, and meat. J Clin Microbiol 2000; 38: 4463–4470.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Abu Al-Soud W, Radstrom P . Capacity of nine thermostable DNA polymerases to mediate DNA amplification in the presence of PCR-inhibiting samples. Appl Environ Microbiol 1998; 64: 3748–3753.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Beillard E, Pallisgaard N, van der Velden VHJ, Bi W, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and MRD detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – A Europe Against Cancer Program. Leukemia 2003; 17: 2474–2486.

    Article  CAS  Google Scholar 

  6. Gabert J, Beillard E, van der Velden VHJ, Pallisgaard N, Gottardi E, Cazzaniga G et al. European standardization and quality control program of real time quantitative RT-PCR analysis of fusion gene transcripts for detection of minimal residual disease in leukemia patients. Leukemia 2003; 17: 2318–2357.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J Gabert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Silvy, M., Pic, G., Gabert, J. et al. Improvement of gene expression analysis by RQ-PCR technology: addition of BSA. Leukemia 18, 1022–1025 (2004). https://doi.org/10.1038/sj.leu.2403339

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403339

Search

Quick links